Dermatology Update 2004 Schedule of Events - Click Links to View Abstracts

Click here to download the program in Acrobat PDF format.

Thursday, October 14, 2004 – Stanley Park Ballroom

9:30 – 11:00

Case Studies in Onychomycosis
Non typical onychomycosis cases will be presented. Interaction with the audience on treatment approaches will be facilitated through touch pads.

2:00 – 3:30 Shaping the Management of Psoriasis – Achieving Long-Term Control

2:00 Introduction: Long-term Control – An Unmet Need in Psoriasis Dr. Vincent Ho

2:10 Efalizumab – An Innovative Biological that Combines Safety and Efficacy Kim Papp

2:35 Practical Experience Using Efalizumab Alan Menter

2:55 Integrating Biologic Agents into the Management of Moderate to Severe Psoriasis – A Canadian Expert Panel Consensus Richard Langley

3:15 Conclusions; Q&A Session Vincent Ho

4:00 – 5:00 Novel Findings in Atopic Dermatitis: How To Maximize Treatments

4:00 Opening Dr. Danielle Marcoux

4:05
Immunological Aspects of Atopic Dermatitis: What do we know?
Dr. Thomas Luger

4:35 Emollients and Barrier Function in Atopic Dermatitis Dr. Andre Rougier

4:55 Patients Therapeutic Education: the Role and Benefits of School of Atopy Dr. Danielle Marcoux

5:20 Question and Answer Panel

Friday, October 15, 2004 – Bayshore Ballroom DEF

9:30 – 11:00

Clinical Advances in the Use of Imiquimod

Aldara for AK: Clinical Approaches Dr. Stuart Salasche

Immune Response Modifiers - An Innovative Approach to NMSC Prof. Eggert Stockfleth

11:30 – 1:30 Advancing the Treatment of Psoriasis and Psoriatic Arthritis with Biologic Therapies: Practical Application of Using TNF Antagonists (Lunch provided )

11:30
Introduction, Learning Objectives
Yves P. Poulin, MD, FRCPC

11:40 Biologic Treatment of Psoriatic Arthritis & Psoriasis Kim A. Papp, MD, PhD, FRCPC

12:05 Interpreting the Safety Experience with TNF Antagonists Richard G.B. Langley, MD, FRCPC

12:30 Practical Approaches and Considerations for Using TNF Antagonists in Clinical Practice: US Experience Bruce Strober, MD, PhD

13:10 Close, Q&A Yves Poulin , MD , FRCPC

13:30 Adjourn

2:00 – 3:30 Redefining Efficacy in Psoriasis

Saturday, October 16, 2004 – Bayshore Ballroom DEF

SESSION 1

Chair: Dr. Harvey Lui

7:00 – 8:00
Breakfast

8:00 – 8:05 Opening Remarks Dr. Harvey Lui

8:05 – 8:20 Review of Drugs for the Treatment of of Skin Disease Dr. Stuart Maddin

8:20 – 8:35 Treating Pemphigus Vulgaris with IVIG: Assessing the Strength of Evidence Dr. Neil Shear

8:35 – 8:50 Valycyclovir in the Treatment and Prevention of Herpes Infections Dr. Stephen Tyring

8:50 – 9:05 Immune Response Modifiers - An Innovative Approach to NMSC Prof. Eggert Stockfleth

9:05 – 9:20 Topical Corticoids, New Progress with a Familiar Treatment Dr. John Berth-Jones

9:20 – 9:35 Alefacept: Innovative Dosing and 18 Month US Experience With Case Studies Dr. Alan Menter

9:35 – 9:55 Panel and Questions
9:55 – 10:15 Coffee Break and Poster Exhibits

SESSION 2

Chair: Dr. Jan Dutz

10:15 – 10:30 Current Management of Atopic Dermatitis Dr. Thomas Luger

10:30 – 10:45
The Role of Staphylcococcus Aureus in Atopic Dermatitis:
Dr. Donald Leung

10:45 – 11:00 Oral Retinoids: Rational Design Dr. Kim Papp

11:00 – 11:15 TNF Antagonists in the Treatment of Psoriasis and Psoriatic Arthritis: Case Studies Dr. Bruce Strober

11:15 – 11:30 A Canadian Expert Panel Consensus – Integrating Biologic Agents in the Management of Moderate to Severe Psoriasis Dr. Richard Langley

11:30 – 11:45 Pimecrolimus for Atopic Dermatitis and Where Do We Go From Here? Prof. Klaus Wolff

11:45 – 12:05 Panel and Questions

RAPID FIRE LUNCH

(Bayshore Ballroom ABC)
Chair: Dr. Richard Thomas

12:05 – 2:00
1. CellCept®: A New and Emerging Therapy
Dr. Regine Mydlarski

2. The Effect of Periocular Hemangiomas on Visual Development in Children Dr. Bryce Cowan

3. Treating Mycosis Fungoides: What, How, Why? Dr. Marni Wiseman

4. A Brief Review of Eczema Management Dr. Jim Bergman

SESSION 3

Chair: Dr. Jerry Shapiro

2:00– 2 :15 Genetic Applications in Dermatology Mr. Greg Hines

2:15 – 2:30 Development of Immune Response Modifiers Dr. Richard Miller

2:30 – 2:50 Photoaging: Update and Treatment Dr. Sheldon Pinnell

2:50 – 3:05 Panel and Questions

3:05 – 3:30 Coffee Break and Poster Exhibits

SESSION 4

Chair: Dr. Neil Shear

3:30 – 3:45
Acne – Quality of Life
Dr. Andrew Finlay

3:45 – 4:00 Sebaceous Gland Targeting With Photodynamic Therapy (PDT) Dr. David Hunt

4:00 – 4:15 Topical Retinoids and their Effect On Inflammatory Mediators in Acne Dr. Sewon Kang

4:15 – 4:30 An Update on the Management of Onychomycosis Dr. Aditya Gupta

4:30 – 4:50 Panel and Questions

4:50 – 5:20 Acute Skin Failure Session

Canadian Consensus Consult Guidelines Dr. Ron Vender

Treatment of Acute Skin Failure Dr. Ian Landells and Dr. Kevin Smith

Who's Who in Canadian Dermatology Dr. Chuck Lynde

The Father of All Azoles Dr. Geert Cauwenbergh

Session Summary Dr. Richard Thomas

5:20 – 5:25 Closing Comments Dr. Stuart Maddin

GALA DINNER

Please join us in celebrating Dermatology Update's 20 th Anniversary. Attire is business formal or black tie. Pre registration is required (tickets will be on sale until Thursday, October 14th as all seats will be pre-assigned).

7:30 – 8:00 Reception

8:00 – 11:00 Dinner

Sunday, October 17, 2004 – Oak Room

CLINICAL TRIAL WORKSHOP - L8

8:00 - 8:30 Breakfast

8:30 - 10:45 Clinical Trial Workshop

• How to Prepare and Adhere to a Realistic Clinical Trial Budget

• What do sponsors and CRO's look for in Selecting a Clinical Trial Site

• Staffing Your Clinical Trial Site: How to Hire and Retain Good Staff

10:45 - 11:00 Questions and Answers

Workshop Presenters:

- Lynne Bulger, Associate Medical Director, Dermatology Team Leader, Hoffmann-La Roche

- Dr. Paul Kidson, Associate Director, Research and Development, Leo Pharma

Registration Fee: $160.50 - pre-registration required